Insights Ahead: Champions Oncology's Quarterly Earnings

Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Monday, 2025-09-15. Here's what investors need to know before the announcement.

Analysts estimate that Champions Oncology will report an earnings per share (EPS) of $-0.01.

Anticipation surrounds Champions Oncology's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Historical Earnings Performance

In the previous earnings release, the company beat EPS by $0.13, leading to a 14.19% drop in the share price the following trading session.

Here's a look at Champions Oncology's past performance and the resulting price change:

Quarter	Q4 2025	Q3 2025	Q2 2025	Q1 2025
EPS Estimate	-0.20	0.30	0.01	-0.03
EPS Actual	-0.07	0.36	0.05	0.11
Price Change %	-14.000000000000002%	-2.0%	-12.0%	10.0%

Champions Oncology Share Price Analysis

Shares of Champions Oncology were trading at $6.46 as of September 11. Over the last 52-week period, shares are up 28.6%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Champions Oncology visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.